Allarity Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Allarity Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $2.00K, a 99.98% decline year-over-year.
- Allarity Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $2.45M, a 54.84% decline year-over-year.
- Allarity Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $9.73M, a 24217.50% increase year-over-year.
- Allarity Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $5.43M.
- Allarity Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2024 was $38.77M.
- Allarity Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2020 was $3.03M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $2.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.45M 10-Q · filed 2025-11-14 | |
| 2025-03-31 | $9.73M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $38.77M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $5.43M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $27.65M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $40.00K 10-Q · filed 2025-11-14 | |
| 2022-06-30 | -$1.38M 10-Q · filed 2022-10-07 | |
| 2022-03-31 | -$133.00K 10-Q · filed 2022-10-07 | |
| 2021-09-30 | $3.25M 10-Q/A · filed 2022-05-17 | |
| 2021-06-30 | $12.13M 10-Q/A · filed 2022-05-17 | |
| 2020-12-31 | $3.03M 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |